About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,620 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,620 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2321-2340 of 6,620 trials

UnknownIBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are the most common inert non Hodgkin's lymphoma (iNHL).NCT05073250·Beijing Active not recruitingGPL in Patients with Relapsed/refractory Diffuse Large B Cell LymphomaProspective, open-ended, single-arm, multicenter Phase II clinical trial.NCT05335018·Seoul RecruitingJY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaThis study is an investigator-initiated single center, single arm clinical study with a target population of patients with relapsed or refractory B cell lymphoma / leukemia.NCT06940960·Guangzhou, Guangdong TerminatedVorinostat in Patients With Primary Cutaneous T-Cell LymphomaThis phase II trial studies the side effects and how well vorinostat works in treating patients with primary cutaneous T-cell lymphoma.NCT00958074·Seattle, Washington

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

TerminatedPhase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)The primary objective of this study is to assess objective response rate (ORR) in patients with relapsed or refractory MCL who failed ibrutinib treatment or were unable to…NCT02455297·Baltimore, Maryland and 4 others

CompletedClinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaThe purpose of this study is to determine the dose of the bispecific T cell engager blinatumomab (MT103) in pediatric and adolescent patients with relapsed/refractory acute…NCT01471782·Aurora, Colorado and 29 others

TerminatedCCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaThis phase II trial is studying how well CCI-779 works in treating patients with relapsed or refractory chronic lymphocytic leukemia.NCT00086840·Houston, Texas

CompletedMolecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's LymphomaRATIONALE: Analyzing genes that are present in cancer cells may be useful as a method for predicting the response of non-Hodgkin's lymphoma to cancer treatment.NCT00055640·Cleveland, Ohio

CompletedA Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell NeoplasmsThe purpose of this study is to assess the safety profile of brentuximab vedotin sequentially and in combination with multi-agent chemotherapy in front-line treatment for…NCT01309789·Birmingham, Alabama and 10 others

TerminatedBendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaThis trial studies how well bendamustine and rituximab in combination with copanlisib work in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.NCT04155840·Seattle, Washington

CompletedCombination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002521·Philadelphia, Pennsylvania

CompletedBortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsBortezomib may stop the growth of cancer cells by blocking the enzymes necessary for their growth.NCT00082784·Tampa, Florida and 4 others

CompletedStudy of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationIn this trial, the investigators will begin to explore the possibility that, as in mice, janus kinase inhibitor 1 (JAK1) inhibition with haploidentical-hematopoietic cell…NCT03755414·St Louis, Missouri

CompletedA Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionThe purpose of this study is to characterize the pharmacokinetics (what the body does to the study medication) of JNJ-38518168 at approximately steady-state (stable medication…NCT01863784·Orlando, Florida and 2 others

CompletedReduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesThis phase II trial studies reduced-intensity conditioning before donor stem cell transplant in treating patients with high-risk hematologic malignancies.NCT01760655·Philadelphia, Pennsylvania

RecruitingGolidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaThis is a multicenter, randomized, double-blind, placebo-controlled phase III trial evaluating golidocitinib as maintenance therapy in adult patients with peripheral T-cell…NCT07300514·Shanghai

CompletedCardiac Safety Study of Brentuximab Vedotin (SGN-35)The purpose of this study is to evaluate cardiac safety of brentuximab vedotin (SGN-35) in patients with CD30-positive cancers.NCT01026233·Birmingham, Alabama and 8 others

TerminatedBendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell LymphomaThis phase II trial studies how well bendamustine hydrochloride, obinutuzumab, and dexamethasone work in treating older patients with diffuse large B-cell lymphoma.NCT02420210·Chicago, Illinois

Active not recruitingLiso-Cel in Relapsed/Refractory Marginal Zone LymphomaThis non-interventional study will use information already reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) registry during routine clinical…NCT07777120·Milwaukee, Wisconsin

WithdrawnTrial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in ChildrenThe objective of this randomized control trial is to investigate the efficacy of an adjunct positive airway pressure (PAP) nebulizer device known as "AccuPAP" in the treatment of…NCT02458482·Nashville, Tennessee

PreviousPage 117 of 331Next